Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Which Big Pharma Is Poised to See Long-Term Gains?
Motley Fool
Thursday, November 7, 2013 - 11:00am
tags:
Bristol-Myers Squibb
Post-DoJ settlement, GlaxoSmithKline toes the line in Breo launch
Fierce Pharma
Thursday, November 7, 2013 - 10:11am
tags:
drug launches, GSK, Advair, Breo Ellipta
Scientists Try To Drag Drug Trials Into The DNA Age
Forbes
Thursday, November 7, 2013 - 10:04am
tags:
clinical trials
Hospira beats the Street with 3rd-quarter earnings
Mass Device
Thursday, November 7, 2013 - 9:57am
tags:
earnings, Hospira, devices
FTC OKs Rule Change For Patent Deals Over Pharma Objections
Pharmalot
Thursday, November 7, 2013 - 9:55am
tags:
patents, FTC
Agenus genital herpes vaccine succeeds in mid-stage trial
Reuters
Thursday, November 7, 2013 - 9:53am
tags:
vaccines, Agenus, genital herpes, HerpV
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thursday, November 7, 2013 - 9:52am
tags:
Gilead, hepatitis C, AbbVie, Bristol-Myers Squibb, JNJ, Merck, simeprevir, sofosbuvir, daclatasvir
5 Revenue-Growing Biotechs With Attractive Fundamentals
Seeking Alpha
Thursday, November 7, 2013 - 9:49am
tags:
Jazz Pharmaceuticals, Alexion, Questcor, Celgene, Regeneron
Omeros' OMS721 shows positive Phase 1 clinical trial results
Yahoo/Fly on the Wall
Thursday, November 7, 2013 - 9:48am
tags:
Omeros, OMS721
New Roche leukemia drug shows clear advantage over Rituxan-study
Yahoo/Reuters
Thursday, November 7, 2013 - 9:46am
tags:
Roche, Rituxan, GA101, Gazyva
Geron soars after myelofibrosis drug shows 44% response rate
The Fly on the Wall
Thursday, November 7, 2013 - 9:45am
tags:
myelofibrosis, Geron, imetelstat
Pozen Inc: Huge Special Dividend And PDUFA On The Horizon Equal Big Gains
Seeking Alpha
Thursday, November 7, 2013 - 8:18am
tags:
Pozen, Omeprazole, Sanofi, PA8140
Glaxo Sells Bad With Good in Safety Push Amid China Woes
Bloomberg
Thursday, November 7, 2013 - 8:16am
tags:
GSK, China
Novartis to add 175 jobs in Cambridge, cut elsewhere
Boston Globe, MA
Thursday, November 7, 2013 - 8:15am
tags:
Novartis, Boston, restructuring
Alnylam 4Q loss widens on fewer drug partnerships
Yahoo/AP
Thursday, November 7, 2013 - 8:13am
tags:
Alnylam, earnings
The Good, Bad, and Ugly of VIVUS' Earnings
Motley Fool
Thursday, November 7, 2013 - 8:11am
tags:
Vivus, earnings
Questcor: Continued Strong Earnings Will Drive It Over $90
Seeking Alpha
Thursday, November 7, 2013 - 8:10am
tags:
Questcor, earnings
Troubled Merck Puts Hopes in New HPV Vaccine
Motley Fool
Wednesday, November 6, 2013 - 5:13pm
tags:
HPV, vaccines, Merck, V503
With Qsymia still flailing, Vivus to cut 20 jobs, replace CFO
Fierce Pharma
Wednesday, November 6, 2013 - 3:37pm
tags:
Vivus, layoffs, Qsymia
AstraZeneca Asks Court Not to Revive Whistleblower Suit
Bloomberg
Wednesday, November 6, 2013 - 3:33pm
tags:
AstraZeneca, Medco, whistleblower lawsuits, kickbacks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.